TAS2R38 and cystic fibrosis: Thus, TAS2R38 can be considered a novel CF modifier gene, that modulates the severity of sinonasal disease contributing to explaining the known discordance for sinonasal severity observed in CF patients with the same CFTR genotype and in some pairs of CF patients4.